Belpointe Asset Management LLC has $1.05M position in Centene Co. (NYSE:CNC)

Belpointe Asset Management LLC raised its stake in shares of Centene Co. (NYSE:CNC – Free Report) by 11.8% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 15,764 shares of the company’s stock after purchasing an additional 1,663 shares during the period. Belpointe Asset Management LLC’s holdings in Centene were worth $1,045,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CNC. Rise Advisors LLC bought a new stake in Centene in the 1st quarter valued at $25,000. WR Wealth Planners LLC boosted its position in shares of Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares during the period. Riverview Trust Co raised its stake in shares of Centene by 154.6% in the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after acquiring an additional 320 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new position in Centene in the second quarter valued at approximately $36,000. Finally, Neo Ivy Capital Management purchased a new stake in Centene in the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 93.63% of the company’s shares.

The Wall Street analyst weighs in

A number of equities research analysts recently weighed in on CNC shares. Stephens reiterated an “equal weight” rating and issued a $78.00 target price on shares of Centene in a research report on Monday, August 5th. Oppenheimer cut their price target on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, July 29th. StockNews.com upgraded Centene from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 29th. Baird RW raised shares of Centene to a “hold” rating in a research report on Thursday, May 30th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Centene from $85.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Seven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Moderate Buy” and an average target price of $85.75, based on data from MarketBeat.

Get the latest analysis on CNC

Centene stock down 0.8%

Shares of CNC stock opened at $72.67 on Friday. The stock has a market cap of $38.78 billion, a price-to-earnings ratio of 14.45, a PEG ratio of 1.06 and a beta of 0.50. Centene Co. it has a 52 week low of $62.50 and a 52 week high of $81.42. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17, and a current ratio of 1.17. The stock has a fifty day moving average of $72.80 and a 200 day moving average of $73.90.

Centene (NYSE:CNC – Get Free Report ) last posted its quarterly earnings results on Friday, July 26th. The company reported $2.42 earnings per share for the quarter, missing the consensus estimate of $2.44 by ($0.02). The firm had revenue of $39.84 billion for the quarter, compared to the consensus estimate of $36.83 billion. Centene had a return on equity of 14.45% and a net margin of 1.79%. The company’s revenue for the quarter was up 5.9% year over year. In the same quarter last year, the firm posted earnings of $2.10 per share. As a group, sell-side analysts anticipate that Centene Co. will post 6.84 earnings per share for the current fiscal year.

Profile Centene

(Free report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to underinsured and uninsured families, commercial organizations and military families in the United States. The company operates through Medicaid, Medicare, Commercial and Other segments. The Medicaid segment provides health plan coverage, including Medicaid expansion, elderly, blind, disabled, children’s health insurance program, foster care, Medicare-Medicaid plans, services and long-term care.

Featured stories

Want to see what other hedge funds CNC owns? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Centene Co. (NYSE:CNC – Free Report).

Get news and reviews for Centene Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Centene and related companies with MarketBeat.com’s FREE daily email newsletter.